DrugDashboards

Market view

tolterodine · Capsule, Extended Release

11 marketed package NDCs · 2 active manufacturers

Most dispensed: TARTRATE 2 mg · Capsule, Extended Release · #30 blister packs/box, unit-dose / 1 capsule, extended release in 1 blister pack · TARTRATE 4 mg · Capsule, Extended Release · #30 blister packs/box, unit-dose / 1 capsule, extended release in 1 blister pack · TARTRATE 4 mg · Capsule, Extended Release · #30 blister packs/carton / 1 capsule, extended release in 1 blister pack · TARTRATE 4 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 16% over the past year, to $0.2573 per unit.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$2.00$4.00$6.00Sep 2015Sep 202603companies actively selling

Latest · Sep 2026 — typical price $0.2573 · middle half $0.2533$0.2648 · full range $0.2533$0.2648 · 9 products · 2 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for tolterodine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Cholinergic Muscarinic Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Tolterodine in shortage right now?
No. FDA does not currently list Tolterodine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Tolterodine?
3 companies have marketed Tolterodine in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Tolterodine cost?
The typical pharmacy pays about $0.2573 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.